Contents

Current Pharmaceutical Design, Volume 9 - Number 27

Preface [Hot topic: Implications of COX-2 Inhibition in the Gastrointestinal Tract (Executive Editor : Angel Lanas)]

, 9(27): ii

Angel Lanas


DOI: 10.2174/1381612033454045




Cyclooxygenase-2 Biology

, 9(27): 2177 - 2190

Joan Claria


DOI: 10.2174/1381612033454054




Dual COX Inhibition and Upper Gastrointestinal Damage

, 9(27): 2191 - 2195

M. M. Skelly and C. J. Hawkey


DOI: 10.2174/1381612033453965




Gastroduodenal Safety of Cyclooxygenase-2 Inhibitors

, 9(27): 2197 - 2206

James M. Scheiman


DOI: 10.2174/1381612033454018




Mucosal Repair and COX-2 Inhibition

, 9(27): 2207 - 2211

Rafael F. Perini, Li Ma and John L. Wallace


DOI: 10.2174/1381612033454027




COX-2 Inhibition, H. pylori Infection and the Risk of Gastrointestinal Complications

, 9(27): 2213 - 2219

Francis K.L. Chan


DOI: 10.2174/1381612033453974




COX-2 Inhibition Versus Gastroprotection with Dual COX Inhibitors: An Evidence-Based Approach

, 9(27): 2221 - 2228

Alexander J.V. Thompson and Neville D. Yeomans


DOI: 10.2174/1381612033453956




COX-2 and Colorectal Cancer

, 9(27): 2229 - 2251

A. Ferrandez, S. Prescott and R. W. Burt


DOI: 10.2174/1381612033454036




Clinical Implications of COX-1 and / or COX-2 Inhibition for the Distal Gastrointestinal Tract

, 9(27): 2253 - 2266

Angel Lanas, Julian Panes and Josep M. Pique


DOI: 10.2174/1381612033453992




COX-2 Inhibition in Esophagitis, Barretts Esophagus and Esophageal Cancer

, 9(27): 2267 - 2280

E. Piazuelo, P. Jimenez and A. Lanas


DOI: 10.2174/1381612033454009




Cyclooxygenase-2 Inhibition and Gastric Cancer

, 9(27): 2281 - 2288

Xiao Hua Jiang and C. Y. Wong


DOI: 10.2174/1381612033453983




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science